Atopic Dermatitis (Eczema)
We are currently looking for participants in two different Atopic Dermatitis (Eczema) clinical trials being conducted at our Johnston, RI location.
Clinical Partners is a dedicated research site conducting Phase II-IV clinical trials. Our staff is comprised of physicians, registered nurses and clinical research coordinators. We are able to conduct in-patient and outpatient trials through our hospital affiliations.
Our Clinical Trials do not cost money to participate in, and no health insurance is necessary.
Trial for Moderate to Severe Atopic Dermatitis (Eczema). Participants can be Male or Female ages 12 years or older. The trial is 24 weeks of treatment using an injection form of medication with a 12 week follow up visit. Trial medication is already approved by the FDA for the treatment of asthma. Participants must have had prior treatment of at least 1 dose of dupilumab (Dupixent).
Trial for Moderate to Severe Atopic Dermatitis (Eczema). Participants can be Male or Female ages 12 years or older. The trial is 16 weeks of treatment using an injection form of medication with 3 follow up visits, for a total of 24 weeks. Participants must have had prior treatment of at least 1 dose of dupilumab (Dupixent).